2020
DOI: 10.1186/s43094-020-00151-w
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes and cardiovascular disease: inter-relation of risk factors and treatment

Abstract: Background The diabetes mellitus prevalence is still advancing and increasingly becoming one of the globally most severe and expensive chronic illnesses. The strong correlation between diabetes as well as the most prominent reason for diabetes and death in diabetic patients is cardiovascular disorders. Health conditions like dyslipidemia, hypertension, obesity, and other factors of risk like the risk of cardiovascular are frequent in diabetic persons and raise the likelihood of heart attacks. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(26 citation statements)
references
References 202 publications
(198 reference statements)
0
25
0
1
Order By: Relevance
“…CVDs are connected to T2D and obesity because of the correlation of inflammation (low grade), as demonstrated in Figure 2 . The over-expression of cytokines, such as interleukin-6 (IL-6), IL-1, leptin, plasminogen activator inhibitor-1 (PAI-1), resistin monocyte chemo attractant protein-1 (MCP-1), angiotensin and tumor necrosis factor-α (TNF-α) fibrinogen, causes inflammation and lipid accumulation, which has a disastrous effect on blood vessels and can eventually cause endothelial dysfunction, cardiomyopathy and myocardial infarction [ 128 , 129 , 130 , 131 ]. The over-expression of these cytokines is linked to the connection between insulin resistance and T2D.…”
Section: Linkage Between Consumption Of Whole Grains and The Developm...mentioning
confidence: 99%
See 1 more Smart Citation
“…CVDs are connected to T2D and obesity because of the correlation of inflammation (low grade), as demonstrated in Figure 2 . The over-expression of cytokines, such as interleukin-6 (IL-6), IL-1, leptin, plasminogen activator inhibitor-1 (PAI-1), resistin monocyte chemo attractant protein-1 (MCP-1), angiotensin and tumor necrosis factor-α (TNF-α) fibrinogen, causes inflammation and lipid accumulation, which has a disastrous effect on blood vessels and can eventually cause endothelial dysfunction, cardiomyopathy and myocardial infarction [ 128 , 129 , 130 , 131 ]. The over-expression of these cytokines is linked to the connection between insulin resistance and T2D.…”
Section: Linkage Between Consumption Of Whole Grains and The Developm...mentioning
confidence: 99%
“…According to the authors, there will be a 69% increase in the number of adults with T2D in developing countries and a 20% increase in developed countries between 2010 and 2030. Wholegrain cereals’ consumption is related to a lower incidence of T2D [ 6 , 73 , 75 , 79 , 80 , 88 , 131 ]. In long-term studies of almost 90,000 women [ 142 ] and nearly 45,000 men [ 143 ], it has been documented that the intake of whole grains can lower the risk of developing T2D, when combined data from both studies show an approximately 30% lower risk of developing T2D found in those who used more whole-grain dietary fibres compared to others.…”
Section: Linkage Between Consumption Of Whole Grains and The Developm...mentioning
confidence: 99%
“…The other reason might be due to DM-induced high blood pressure increases the force of blood through arteries and can damage artery walls. Moreover, too much cholesterol and triglyceride can form plaque resulting in the hardening of arterial walls [ 40 ] which can finally lead to ECG changes.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of CVD usually includes lifestyle changes, medications, and procedures to help open blood vessels. Currently, a large number of medications are available to ameliorate the risks factors of CVD, such as diabetes, hypertension, coagulation, and dyslipidemia [77,78]. Clinical studies, including the CVD-REAL Nordic trial, demonstrated that glucose co-transporter-2 (SGLP2) inhibitors decreases cardiovascular morbidity and mortality in patients with type 2 diabetes and cardiovascular disease [79][80][81].…”
Section: Cardiovascular Diseasesmentioning
confidence: 99%